Gene · 8740
Papers1,880
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
321 to 340 of 1,880
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Comprehensive epigenomic profiling reveals the extent of disease-specific chromatin states and informs target discovery in ankylosing spondylitis. | Cell Genom | 2023 | 37388915 | PubTator, text mining | PubMed |
| Single-cell RNA sequencing highlights the role of PVR/PVRL2 in the immunosuppressive tumour microenvironment in hepatocellular carcinoma. | Front Immunol | 2023 | 37383234 | PubTator, text mining | PubMed |
| Overexpression of DBT suppresses the aggressiveness of renal clear cell carcinoma and correlates with immune infiltration. | Front Immunol | 2023 | 37383233 | PubTator, text mining | PubMed |
| Influence of SARS-CoV-2 Status and Aging on the Nasal and Fecal Immunological Profiles of Elderly Individuals Living in Nursing Homes. | Viruses | 2023 | 37376702 | PubTator, text mining | PubMed |
| Obesity, non-alcoholic fatty liver disease and hepatocellular carcinoma: current status and therapeutic targets. | Front Endocrinol (Lausanne) | 2023 | 37361533 | PubTator, text mining | PubMed |
| Prognostic prediction and immunotherapy response analysis of the fatty acid metabolism-related genes in clear cell renal cell carcinoma. | Heliyon | 2023 | 37360096 | PubTator, text mining | PubMed |
| A predictive molecular signature consisting of lncRNAs associated with cellular senescence for the prognosis of lung adenocarcinoma. | PLoS One | 2023 | 37352167 | PubTator, text mining | PubMed |
| Bioinformatics analysis of necroptosis‑related lncRNAs and immune infiltration, and prediction of the prognosis of patients with esophageal carcinoma. | Exp Ther Med | 2023 | 37346407 | PubTator, text mining | PubMed |
| An amino acid metabolism-based seventeen-gene signature correlates with the clinical outcome and immune features in pancreatic cancer. | Front Genet | 2023 | 37333498 | PubTator, text mining | PubMed |
| Multi-omic longitudinal study reveals immune correlates of clinical course among hospitalized COVID-19 patients. | Cell Rep Med | 2023 | 37327781 | PubTator, text mining | PubMed |
| Identification of neoantigens and immunological subtypes in clear cell renal cell carcinoma for mRNA vaccine development and patient selection. | Aging (Albany NY) | 2023 | 37315301 | PubTator, text mining | PubMed |
| Methotrexate Provokes Disparate Folate Metabolism Gene Expression and Alternative Splicing in Ex Vivo Monocytes and GM-CSF- and M-CSF-Polarized Macrophages. | Int J Mol Sci | 2023 | 37298590 | PubTator, text mining | PubMed |
| NK Cells in Cancer: Mechanisms of Dysfunction and Therapeutic Potential. | Int J Mol Sci | 2023 | 37298470 | PubTator, text mining | PubMed |
| Serum proteomics in giant cell arteritis in response to a three-day pulse of glucocorticoid followed by tocilizumab monotherapy (the GUSTO trial). | Front Immunol | 2023 | 37287970 | PubTator, text mining | PubMed |
| Mediating immunosuppressive functions: a new perspective on the complex immunological properties of SEMA4D in the tumor microenvironment. | Front Oncol | 2023 | 37287907 | PubTator, text mining | PubMed |
| MMP14 is a diagnostic gene of intrahepatic cholangiocarcinoma associated with immune cell infiltration. | World J Gastroenterol | 2023 | 37274806 | PubTator, text mining | PubMed |
| Knocking down NSUN5 inhibits the development of clear cell renal cell carcinoma by inhibiting the p53 pathway. | Aging (Albany NY) | 2023 | 37263638 | PubTator, text mining | PubMed |
| Combined analysis of single-cell and bulk RNA sequencing reveals the expression patterns of circadian rhythm disruption in the immune microenvironment of Alzheimer's disease. | Front Immunol | 2023 | 37251379 | PubTator, text mining | PubMed |
| Identification of ferroptosis and drug resistance related hub genes to predict the prognosis in Hepatocellular Carcinoma. | Sci Rep | 2023 | 37248280 | PubTator, text mining | PubMed |
| Redox Signaling Modulates Activity of Immune Checkpoint Inhibitors in Cancer Patients. | Biomedicines | 2023 | 37238995 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8740/papers?page=17